Amphastar Pharmaceuticals AMPH Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's interest paid?
- Amphastar Pharmaceuticals (AMPH) reported interest paid of $7.3M in Q1 2026.
- How has Amphastar Pharmaceuticals's interest paid changed year-over-year?
- Amphastar Pharmaceuticals's interest paid decreased by 3.8% year-over-year, from $7.58M to $7.3M.
- What is the long-term trend for Amphastar Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's interest paid has grown at a 82.2% compound annual growth rate (CAGR), from $2.11M to $23.22M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.